FDA Considers Johnson & Johnson COVID-19 Vaccine For Emergency Use Authorization

An advisory committee to the Food and Drug Administration met to consider the application for emergency use authorization for the Janssen, the vaccine division of Johnson & Johnson, COVID-19 vaccine.